Insights into Atara Biotherapeutics's Upcoming Earnings

Atara Biotherapeutics ATRA is gearing up to announce its quarterly earnings on Tuesday, 2024-11-12. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Atara Biotherapeutics will report an earnings per share (EPS) of $-1.93.

Atara Biotherapeutics bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Performance in Previous Earnings

The company's EPS missed by $1.54 in the last quarter, leading to a 3.22% increase in the share price on the following day.

Here's a look at Atara Biotherapeutics's past performance and the resulting price change:

Tracking Atara Biotherapeutics's Stock Performance

Shares of Atara Biotherapeutics were trading at $11.31 as of November 08. Over the last 52-week period, shares are up 41.23%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.

To track all earnings releases for Atara Biotherapeutics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.